Cargando…

Short-term variation of HIV tropism readouts in the absence of CCR5 antagonists

Detalles Bibliográficos
Autores principales:	Brumme, CJ, Dong, W, Chan, D, Mo, T, Swenson, LC, Woods, C, Demarest, J, Heera, J, Valdez, H, Harrigan, PR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112871/ http://dx.doi.org/10.1186/1758-2652-13-S4-O9

Ejemplares similares

Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype
por: Swenson, LC, et al.
Publicado: (2010)

Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients
por: Valdez, H, et al.
Publicado: (2010)

First prospective comparison of genotypic vs phenotypic tropism assays in predicting virologic responses to Maraviroc (MVC) in a phase 3 study: MODERN
por: Heera, Jayvant, et al.
Publicado: (2014)

CCR5 and CXCR4 antagonist and agonist binding sites
por: Teintze, Martin, et al.
Publicado: (2006)

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy
por: Lee, Guinevere Q., et al.
Publicado: (2014)

Population and ultra-deep sequencing for tropism determination are correlated with Trofile ES: genotypic re-analysis of the A4001078 maraviroc study
por: Portsmouth, S, et al.
Publicado: (2010)

Effect of 24 weeks of intensification with a CCR5-antagonist on the decay of the HIV-1 latent reservoir
por: Díaz, L, et al.
Publicado: (2010)

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes
por: Cashin, Kieran, et al.
Publicado: (2015)

Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing
por: Vandekerckhove, LPR, et al.
Publicado: (2010)

Co-receptor usage prediction at quasispecies level using ultra-deep pyrosequencing on both circulating and proviral hiv in patients candidates to CCR5 antagonist treatment
por: Abbate, Isabella, et al.
Publicado: (2010)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

P306 Scedosporium spp. and Lomentospora prolificans, fungal agents with unexpected vascular tropism
por: Vignals, Carole, et al.
Publicado: (2022)

Latency, tropism and genetic variation of Simian Foamy Virus in blood and saliva from infected Humans
por: Rua, Réjane, et al.
Publicado: (2014)

IFN-α-Induced Upregulation of CCR5 Leads to Expanded HIV Tropism In Vivo
por: Stoddart, Cheryl A., et al.
Publicado: (2010)

CCR9 Antagonists in the Treatment of Ulcerative Colitis
por: Bekker, Pirow, et al.
Publicado: (2015)

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
por: Seclén, E, et al.
Publicado: (2010)

Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program
por: Lazzarin, A, et al.
Publicado: (2010)

Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
por: Hütter, Gero
Publicado: (2011)

An unprecedented and simple gp120 switch mechanism enables HIV-1 to overcome multiple entry inhibitors and tropism limitations
por: Platt, Emily, et al.
Publicado: (2006)

Absence vs. presence
por: Ramkumar, Swaminathane
Publicado: (2014)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

Baseline HIV-1 tropism prediction in advanced immune suppressed patients: evidence of CXCR4 viruses in IDUs infected with recombinant forms
por: Paraschiv, Simona, et al.
Publicado: (2014)

CCR6 mediates the intracellular HIV inhibitory activity of human beta-defensin 2
por: Sun, Lingling, et al.
Publicado: (2006)

The global distribution of CCR5 delta 32 polymorphism: role in HIV-1 protection
por: Gupta, Anuroopa, et al.
Publicado: (2012)

Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model
por: Okamoto, Masayuki, et al.
Publicado: (2013)

Chemokine receptor CCR5 mediates resistance to West Nile Virus infection in mouse and man
por: Murphy, Philip
Publicado: (2006)

Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
por: Olson, William C
Publicado: (2006)

Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection
por: Lopalco, Lucia, et al.
Publicado: (2006)

What is the future of CCR5 antagonists in rheumatoid arthritis?
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction
por: Le, Anh Q., et al.
Publicado: (2015)

Molecular determinants analysis and co receptor tropism prediction of V3 loop of HIV-1 “C” clade sequences isolated from India using insilico approach
por: Christy, H Jemmy, et al.
Publicado: (2012)

CCR9+ and CD103+ tolerogenic dendritic cell populations in food allergy patients undergoing oral immunotherapy
por: Garcia, Marco, et al.
Publicado: (2011)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Anti-CCR4 antibody activates virus specific immune response in STLV-1 infected Japanese monkey
por: Sugata, Kenji, et al.
Publicado: (2015)

In silco analysis of carboxamide derivatives of piperidine as potential antagonists of CCR5
por: Harishchander, A, et al.
Publicado: (2014)

P16-41. Evidence for in vivo immune selection pressure exerted by HLA class I restricted CTL responses to anti-sense encoded HIV sequences
por: Berger, CT, et al.
Publicado: (2009)

Evolution of coreceptor utilization to escape CCR5 antagonist therapy
por: Zhang, Jie, et al.
Publicado: (2016)

The reciprocal antagonistic interplay between HIV-1 Tat and SIN3A specifies the epigenetic switch between de-repression versus maintenance of HIV-1 gene silencing
por: Kulkarni, Anurag, et al.
Publicado: (2013)

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
por: Lefebvre, Eric, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0mberft92lbrl597sbm7snlvc5